Publicaciones en colaboración con investigadores/as de Memorial Sloan Kettering Cancer Center (20)

2023

  1. Detection of novel therapies using a multi-national, multi-institutional registry of cutaneous immune-related adverse events and management

    International Journal of Dermatology, Vol. 62, Núm. 8, pp. 1020-1025

  2. Supportive oncodermatology practices in Europe and the USA

    Journal of the European Academy of Dermatology and Venereology

2022

  1. European recommendations for management of immune checkpoint inhibitors-derived dermatologic adverse events. The EADV task force ‘Dermatology for cancer patients’ position statement

    Journal of the European Academy of Dermatology and Venereology, Vol. 36, Núm. 3, pp. 332-350

  2. Shared decision making for patients with breast and gynecologic malignancies undergoing chemotherapy associated with persistent alopecia

    Gynecologic Oncology Reports, Vol. 44

2020

  1. Assessment and Treatment Outcomes of Persistent Radiation-Induced Alopecia in Patients with Cancer

    JAMA Dermatology, Vol. 156, Núm. 9, pp. 963-972

  2. Outpatient dermatology consultations for oncology patients with acute dermatologic adverse events impact anticancer therapy interruption: a retrospective study

    Journal of the European Academy of Dermatology and Venereology, Vol. 34, Núm. 6, pp. 1340-1347

2019

  1. Assessment of Quality of Life and Treatment Outcomes of Patients with Persistent Postchemotherapy Alopecia

    JAMA Dermatology, Vol. 155, Núm. 6, pp. 724-728

  2. Clinical Characterization of Immunotherapy-Related Pruritus among Patients Seen in 2 Oncodermatology Clinics

    JAMA Dermatology

  3. Cryosurgical management of basal cell carcinoma: in vivo follow-up using reflectance confocal microscopy

    International Journal of Dermatology

  4. Hair disorders in cancer survivors

    Journal of the American Academy of Dermatology, Vol. 80, Núm. 5, pp. 1199-1213

  5. Hair disorders in patients with cancer

    Journal of the American Academy of Dermatology, Vol. 80, Núm. 5, pp. 1179-1196

  6. In-vivo assessment of a case of cutaneous sarcoidosis using reflectance confocal microscopy

    Anais Brasileiros de Dermatologia, Vol. 94, Núm. 1, pp. 93-95

  7. Nonmelanoma skin cancer in childhood and young adult cancer survivors previously treated with radiotherapy

    JNCCN Journal of the National Comprehensive Cancer Network, Vol. 17, Núm. 3, pp. 237-243

  8. Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies

    Breast Cancer Research and Treatment, Vol. 174, Núm. 1, pp. 15-26

  9. Treatment outcomes of immune-related cutaneous adverse events

    Journal of Clinical Oncology, Vol. 37, Núm. 30, pp. 2746-2758

2018

  1. Endocrine therapy-induced alopecia in patients with breast cancer

    JAMA Dermatology, Vol. 154, Núm. 6, pp. 670-675

  2. Inflammatory dermatoses, infections, and drug eruptions are the most common skin conditions in hospitalized cancer patients

    Journal of the American Academy of Dermatology, Vol. 78, Núm. 6, pp. 1102-1109

  3. Podiatric adverse events and foot care in cancer patients and survivors: Awareness, education, and literature review

    Journal of the American Podiatric Medical Association, Vol. 108, Núm. 6, pp. 508-516

2017

  1. Eruptive keratoacanthomas associated with pembrolizumab therapy

    JAMA Dermatology, Vol. 153, Núm. 7, pp. 694-697

  2. Monitoring of noninvasive treatment of basal cell carcinoma

    Reflectance Confocal Microscopy of Cutaneous Tumors, Second Edition (CRC Press), pp. 496-512